Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.
Press releases published on April 11, 2025

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to its newly appointed …

The Children’s Place Reports Fourth Quarter and Full Year 2024 Results
Reports Third Consecutive Quarter of Adjusted Operating Profits Net Sales of $409 million for Fourth Quarter and $1.386 billion for Full Year Significant Improvement in Gross Profit Margin to 29% for Fourth Quarter and 33% for Full Year Lowest Level of …

Signing Day Sports Provides Announcement on 2024 Annual Report
SCOTTSDALE, Ariz., April 11, 2025 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), the developer of the Signing Day Sports app and platform to aid high school athletes in the recruitment process, …

Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management L.L.C-FZ (“ …

ParaZero Announces Receipt of Nasdaq Minimum Bid Price Notification
TEL AVIV, Israel, April 11, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems, today announced it …

Hubbell to Announce First Quarter 2025 Results on May 1, 2025
Shelton, CT, April 11, 2025 (GLOBE NEWSWIRE) -- Hubbell Incorporated (NYSE: HUBB) today announced it will release its first quarter 2025 financial results prior to the opening of the market on May 1st, 2025. The Company will then webcast its Analysts' …

Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements
Raanana, Israel, April 11, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today that on April 8, 2025, …

PTL Limited Announces Closing of $7.14 Million Public Offering of its Ordinary Shares
Hong Kong, April 11, 2025 (GLOBE NEWSWIRE) -- PTL Limited (NASDAQ: PTLE) (the “Company”), an established bunkering facilitator providing marine fuel logistics services for vessel refueling, serving the Asia Pacific market, today announced the closing of …

The Memory Wave Under Review: Billionaire Brain Wave Support for Improving Memory
New York City, April 11, 2025 (GLOBE NEWSWIRE) -- In today’s fast-paced, information-heavy world, memory issues can be more than just frustrating—they can be life-altering. The frustration of misplacing your keys, forgetting names, or struggling to recall …

Coca-Cola Consolidated, Inc. Announces Second Quarter Dividend
CHARLOTTE, N.C., April 11, 2025 (GLOBE NEWSWIRE) -- Coca-Cola Consolidated, Inc. (NASDAQ: COKE) announced that its Board of Directors has declared a dividend for the second quarter of 2025 of $2.50 per share on shares of the Company's Common Stock and …

Beam Global Reports Full Year 2024 Operating Results
SAN DIEGO, April 11, 2025 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM), (the “Company”), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation, smart cities, and energy security, today …

4DMT Announces New Employment Inducement Grants
EMERYVILLE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment …

Dynagas LNG Partners LP Announces Filing of Form 20-F With the SEC
ATHENS, Greece, April 11, 2025 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (NYSE:DLNG) (the “Partnership”), an owner and operator of liquefied natural gas (“LNG”) carriers, announced today that it has filed its Annual Report on Form 20-F for the year ended …

Tianci International, Inc. Announces Closing of $7 Million Public Offering
HONG KONG and RENO, Nev., April 11, 2025 (GLOBE NEWSWIRE) -- Tianci International, Inc. (the "Company” or “Tianci”), a global logistics service provider specializing in ocean freight forwarding, today announced the closing of its public offering (the “ …

Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness
CANTON, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

argenx Announces Annual General Meeting of Shareholders on May 27, 2025
April 11, 2025, 10:01 PM CET Amsterdam, the Netherlands – argenx SE (Euronext …

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WOBURN, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly …

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that on April 9, 2025, the compensation …

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, April 11, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier …

iOThree Limited Announces Closing of Initial Public Offering
SINGAPORE, April 11, 2025 (GLOBE NEWSWIRE) -- iOThree Limited ("iOThree" or the "Company") (NASDAQ: IOTR), a leading provider of maritime digital technologies including satellite connectivity and digitalization solutions in Singapore with a focus on …